We are aiming to answer the following questions in a range of settings:
- How do we determine the most cost-effective scale-up of treatments among priority groups, through different modalities, and over different time-frames?
- How much will it cost to reach strategic targets?
- How can the cascade of care be optimised to maximise the number of people receiving curative treatment?
- Where are the bottlenecks?
- Which modalities of which programs are required (e.g. mobile clinics or nurse-led models of care)?
2015-ongoing
Given the limited resources available, we will investigate what the best use of funding across the programs of prevention, testing and treatment might be to:
- Minimise morbidity and mortality
- Minimise new infections
- Get as close as possible to multiple national targets.
Project
Team
Meet the project team. Together, we are translating research into better health, for all.
Publications
VIEW ALL RESEARCHScott N, Doyle JS, Wilson DP, Wade A, Howell J, Pedrana A, Thompson A, Hellard ME
- The International journal on drug policy
- 07 Aug 2017
Scott N, McBryde ES, Thompson A, Doyle JS, Hellard ME
- Gut
- 12 Apr 2016
Snow K, Scott N, Clothier HJ, MacLachlan JH, Cowie B
- Australian and New Zealand journal of public health
- 14 Aug 2016
Stone J, Martin NK, Hickman M, Hellard M, Scott N, McBryde E, Drummer H, Vickerman P
- PloS one
- 25 May 2016
Visconti AJ, Doyle JS, Weir A, Shiell AM, Hellard ME
- Journal of gastroenterology and hepatology
- 24 Sep 2013
Rolls DA, Daraganova G, Sacks-Davis R, Hellard M, Jenkinson R, McBryde E, Pattison PE, Robins GL
- Journal of theoretical biology
- 16 Dec 2011
Scott N, McBryde E, Vickerman P, Martin NK, Stone J, Drummer H, Hellard M
- BMC medicine
- 20 Aug 2015